PRECIGEN, INC. PGEN

Rank #2439 · Nasdaq · $2.5B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

18.5

P/E

-25.8

P/B

19.60

ROE

-76.0%

Op. Margin

-1602.5%

Debt Ratio

62%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -25.8x, P/B 19.60x. Ranks in the top 82% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -76.0%. Ranks in the top 94% of the universe.

Safety ★★★★☆

Good

Debt ratio 62%. Ranks in the top 27% of the universe.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2013	$0.0B	$-0.1B	$-0.1B	$-0.3B	-1028.7	-21
2014	$0.0B	$-0.1B	$-0.1B	$0.4B	-545.6	24
2015	$0.0B	$-0.1B	$-0.0B	$0.4B	-244.2	43
2016	$0.1B	$-0.1B	$-0.1B	$0.7B	-97.3	40
2017	$0.2B	$-0.1B	$-0.1B	$0.6B	-84.6	68
2018	$0.2B	$-0.1B	$-0.2B	$0.5B	-65.6	56
2019	$0.2B	–	$-0.1B	$0.4B	–	93
2020	$0.2B	–	$-0.5B	$0.1B	–	536
2021	$0.1B	–	$-0.3B	$0.1B	–	368
2022	$0.0B	–	$-0.2B	$0.1B	–	352
2023	–	–	$-0.1B	$0.1B	–	134
2024	–	–	$0.0B	$0.1B	–	30
2025	$0.0B	$-0.1B	$-0.1B	$0.1B	-1602.5	62